This site is intended for healthcare professionals only

DiabetesontheNet Logo
×

Diabetes Care for
Children & Young People

Issue:

Share this article
Share on facebook
Share on twitter
Share on email
Share on print

Reducing ethnic inequalities in paediatric diabetes care: A Nottingham perspective

How Nottingham has got significantly ahead of the national average for both for insulin pump provision and HbA1c in Black and Asian children with diabetes, as well as those in the poorest socioeconomic groups.

Ethnic inequality is a fundamental determinant of health (Jee-Lyn García and Sharif, 2015), and racism has been described by Professor Kevin Fenton, of Public Health England (PHE), as a “wicked problem” – a complex problem that is highly resistant to solutions. When discussing a recent report from PHE about the impact of COVID-19 on Black, Asian and minority ethnic (BAME) communities (PHE, 2020), Professor Fenton stated:

“Now is the time for us to recognise the connection between structural racism and racialised disparities in health.”

Recent amplification of the voice of Black Lives Matter and a disproportionate number of deaths from COVID-19 in Black and Asian people has re-focused attention on racial health inequalities. Racial stratification is annually and amply demonstrated in the UK National Paediatric Diabetes Audit (NPDA), which continues to reveal a widening socioeconomic and ethnic disparity in use of technologies associated with lower HbA1c and improved health outcomes (Royal College of Paediatrics and Child Health [RCPCH], 2021).

Nationally, the use of insulin pump therapy is 50% more likely in White British children (39.8%) compared with Black children (26.7%), and yearly mean HbA1c remains higher in Black children, independent of the level of deprivation. Black children in the least deprived quintile have a similar mean HbA1c to White children in the most deprived quintile (68.3 mmol/mol [10.8%] and 68.1 mmol/mol [10.7%], respectively).

Ethnic inequalities, historic and current, underpin the differences in housing, education, employment, and prison sentencing in every stratum of life, and harm all of society. The social determinants of health tend to favour White children over Black children and those of ethnic minorities. This contributes to a lack of trust in “the system”, including healthcare, and often means both children and adults from ethnic minorities may not engage in the therapeutic process as readily as White people. This may be due to cultural reasons, especially if the clinical team are not of the same demographic and services are not shaped to include these minorities. In addition, our own conscious or unconscious bias as healthcare professionals (HCPs) can impact health outcomes.

We aspire to impartiality in the treatment of all our patients, but an excellent systematic review by Fitzgerald and Hurst (2017) shows HCPs demonstrate the same level of implicit bias as the general population. Implicit bias is caused by unconscious associations leading to a negative evaluation of a person on the basis of irrelevant characteristics, such as race or gender. The stronger our implicit bias, the worse care we will unknowingly give as it affects rapport, diagnosis, treatment decisions and levels of care. This impacts on trust between BAME communities and the medical profession. This was recently highlighted by the decreased uptake of COVID-19 vaccines in BAME communities, and this included HCPs from BAME backgrounds. Conversely, increased trust correlates with better glycaemic control, more beneficial health behaviours, fewer symptoms, higher quality of life and increased satisfaction with treatment (Birkhäuer et al, 2017).

Key quality improvement initiatives implemented in England and Wales over the past 10 years have seen a reduction in median HbA1c of 11 mmol/mol, but have done nothing to reduce the discrepancy of around 7 mmol/mol (median HbA1c) between Black and White children, with those of Black ethnicity having the highest average HbA1c year on year (RCPCH, 2021).

The first key principle of the NHS is to provide equality of care and pay particular attention to groups or sections of society where improvements in health and life expectancy are not keeping pace with the rest of the population. With this in mind, we examined data on the 387 children with type 1 diabetes in Nottingham from April 2020 to March 2021, in line with the NPDA methods.

Ethnicity results

Nottinghamshire has always been an early adopter of technology and has higher pump use across all ethnic groups compared with the national figures (Table 1). The mean HbA1c in Nottinghamshire is lower across all ethnic groups than nationally. Most notably, the mean HbA1c is 13.1 mmol/mol lower in Black children in Nottinghamshire (58.8 mmol/mol, compared with 71.9 mmol/mol nationally). The mean HbA1c for children identifying as mixed-ethnicity, however, is only 3.5 mmol/mol lower in Nottingham compared with national figures.

Importantly, the mean HbA1c in Nottinghamshire is almost equal in children identifying as White and Black, with a difference of only 1.7 mmol/mol, compared with a national difference of 7.3 mmol/mol.

Part of Nottingham’s success may be attributed to its “give it a go” attitude, rather than a “will they cope?” approach. There is also intensive multidisciplinary team support for those on the high HbA1c pathway (Fradley et al, 2016).

Socioeconomic results

In Nottinghamshire, the national trend of pump distribution and HbA1c is reversed; the least deprived receive the fewest pumps (41%) and have the highest HbA1c (59.4 mmol/mol), while the most deprived use the most pumps (63%) and have the lowest HbA1c (54.9 mmol/mol). The reasons for the differences are not clear, but if children from the least deprived backgrounds are meeting targets with multiple daily injections, then a pump will not be offered, and for some, the pressure of conforming at private school means they do not want a pump as a visible sign of their diabetes.

Conclusion

Nottingham is significantly ahead of the national average for both for pump provision and HbA1c in Black and Asian children with diabetes, as well as those in the poorest socioeconomic groups. This demonstrates that equality is possible; however, even in Nottingham, some disparity remains. Identifying this is the first step. Becoming aware of unconscious bias and mitigating against barriers to equality will ensure we achieve equitable treatment and outcomes for our patients, as the key principles of the NHS remind us.

On an individual level, there are resources available to help identify implicit bias, such as the 10-minute Harvard Implicit Association Test (https://implicit.harvard.edu/implicit/). There are also implicit bias e-learning modules available through most NHS Trusts. Self awareness of bias should prompt us to seek the professional opinion of a diverse range of colleagues to ensure our decision making is equitable. Furthermore, listening to the patients’ voice, especially in those from ethnic minorities, is key.

On an organisational level, measuring the data facilitates discussion around strategies to reduce discrepancy. Employing an ethnically diverse team (Fradley et al, 2016) is also important.

Further reading

Reni Eddo-Lodge’s book Why I’m no longer talking to White people about Race, provides an excellent overview, illuminating the insidious racial prejudice that pervades our institutions and country.

Birkhäuer J, Gaab J, Kossowsky J et al (2017) Trust in the health care professional and health outcome: a meta-analysis. PLoS One 12: e0170988

Fitzgerald C, Hurst S (2017) Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics 18: 19

Fradley W, Sachdev P, Randell T, Denvir L (2016) High HbA1c pathway for children and young people with poor glycaemic control. Endocrine Abstracts 45: 41

Jee-Lyn García J, Sharif MZ (2015) Black Lives Matter: a commentary on racism and public health. Am J Public Health 105: e27–30

Public Health England (2020) Beyond the data: Understanding the impact of COVID-19 on BAME groups. Public Health England, London. Available at: https://bit.ly/3o03i7k (accessed 4.11.21)

Royal College of Paediatrics and Child Health (2021) National Paediatric Diabetes Audit annual report 2019–20. RCPCH, London. Available at: https://bit.ly/3nQz6M3 (accessed 25.10.21)

Share this article
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
Related content
For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
DiabetesontheNet Logo
For the latest news and articles

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for UK healthcare professionals only. To continue, please confirm that you are a UK healthcare professional below.